JP-1366

DRUG2 trials

Sponsors

Onconic Therapeutics Inc.

Conditions

GERDHealthy

Phase 1

Phase 1 Study of JLP-2302 and JP-1366: PK and Safety in Healthy Volunteers

CompletedNCT07181538

Onconic Therapeutics Inc.Healthy

Start: 2025-02-04End: 2025-03-05Updated: 2025-09-18

Phase 2

Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease

CompletedNCT04282954

Onconic Therapeutics Inc.GERD

Start: 2019-11-15End: 2020-12-11Updated: 2022-07-13